RSS Feeds
All schools in England to get pupil attendance targets, government says
Republican senators vote to hold Dr. Fauci in contempt of Congress
Indian journalist Tarun Tejpal sentenced to 10 years in jail for rape
Livestreamer's murder raises questions over relations between Mexico's creators and cartels
WATCH: Houston man inspires community cleanup
Как я перенёс проверку цен с VPS на компьютеры пользователей — и зачем всё-таки оставил сервер
Сначала PriceTrack проверял страницы маркетплейса на VPS. Селекторы были корректными, но сервер вместо карточек товара получал 403. В итоге я перенёс браузер и извлечение данных на компьютеры пользователей, а сервер оставил управляющим контуром. В статье рассказываю, как устроена эта архитектура, зачем понадобились базовый профиль и локальный рецепт и какие проблемы появились с фоновыми проверками, треем и несколькими аккаунтами.
Читать далееRihanna is 'in the studio', says partner A$AP Rocky
US Senate committee votes to hold Fauci in contempt over Covid hearing
Lindsay Clancy sobs at trial as jury is shown baby's autopsy photos
Как оценивать эффективность разработки
Меня зовут Антон Омельяненко, я Head of Software Development в EXANTE. Менеджер управляет командой так, чтобы она приносила бизнесу результат. Чтобы понимать, насколько хорошо люди справляются с задачами, ему нужны данные о работе и система оценки. С разработкой это сложнее, чем кажется.
В статье я разберу три вопроса: почему классические метрики не подходят для оценки эффективности разработчиков, как измерять её правильно и что делать, если вам кажется, что сотрудник работает не только на вас.
Читать далееMiss North Carolina USA stripped of title after alleged racist posts resurface
First runner-up, Myla Hadley, will represent the state at the Miss USA pageant after Brittany Boltinhouse’s removal
A pageant queen recently crowned Miss North Carolina USA has been stripped of her title after a string of alleged racist posts resurfaced.
Brittany Boltinhouse, 27, was formally dethroned on Wednesday by pageant organizers A Blaize Productions after what it said was “a thorough review of recently surfaced information”.
Continue reading...Jason Arday claimed he was paid ‘1.4 million’ by publisher for memoir
Simon & Schuster still plans to publish book by Cambridge academic who resigned this week amid plagiarism claims
Jason Arday, the former Cambridge professor accused of plagiarism and embellishment, claimed he was paid “1.4 million” for his forthcoming memoir detailing his extraordinary backstory.
Arday was dogged by a growing series of questions over his academic work and credentials before he resigned on Wednesday night, saying the “relentless accusations, speculation and public commentary have taken a profound toll on me and on those I love”.
Continue reading...Nearly 50 asylum seekers deported under ‘one in one out’ scheme have returned to the UK
Figure raises questions about deal with France despite UK ministers insisting repeat arrivals will be removed
Almost 50 asylum seekers deported using the “one in one out” scheme have been recorded as returning to the UK a second time, the Guardian has learned.
In addition to the returnees detained by the Home Office, an unknown number are believed to have arrived in the UK undetected.
Continue reading...Two Iranian female footballers granted Australian citizenship after protest
Players stayed in country after Asian Cup in March
Duo condemned as traitors in Iran for not singing anthem
Two former Iranian footballers said on Thursday they were proud to have been granted Australian citizenship after being called traitors at home for refusing to sing the national anthem before a game.
Fatemeh Pasandideh and Atefeh Ramezanisadeh were members of a group of seven from Iran’s delegation who asked for Australia’s protection after the protest during the women’s Asian Cup in March.
Continue reading...Meta becomes latest firm to say its AI hacked another company
WATCH: Zendaya becomes highest grossing actor in the 2026 box office
US Senate committee votes to hold Fauci in contempt over Covid hearing
FDA Approves the First mRNA Flu Vaccine
On Aug. 5, the U.S. Food and Drug Administration (FDA) approved the first mRNA-based vaccine for influenza. Health experts say the shot, made by Moderna, could have several advantages over traditional flu vaccines, but its approval comes at a time when federal health agencies have walked back recommending flu vaccines for many people.
In a study published in May 2026 in the New England Journal of Medicine that Moderna submitted to the FDA, the mRNA-based flu shot, called mFlusiva, was up to 27% more effective in preventing flu than any of four currently available flu shots. Among more than 40,000 people over age 50 who were randomly assigned to receive either mFlusiva or one of four existing flu shots, those who received a single dose of the mRNA flu vaccine were on average 27% less likely to have lab-confirmed influenza-like illness than those getting another type of flu shot.
“I think this is a historic event and incredibly exciting, both scientifically and from a public-health standpoint,” says Dr. Jeanne Marrazzo, CEO of the Infectious Diseases Society of America.
“Flu remains a significant public health challenge, and mFlusiva provides an important new option for America’s seniors,” said Stéphane Bancel, Moderna’s CEO.
Marrazzo says the mRNA-based flu vaccine is a gamechanger when it comes to matching influenza strains circulating at a given time and in a given region to the flu vaccine. The better the match, the more effective the shot in preventing flu and some of its serious consequences, including pneumonia, respiratory distress, and even organ failure in those who are most vulnerable to infections, which include older people, young children, and those with weakened immune systems.
Because the mRNA technology relies on a genetic plug-and-play model, in which different genetic sequences for any virus or pathogen can be switched into the vaccine, the shot takes around six weeks to develop. Current flu vaccines, on the other hand, take up to six months to create because they require growing the influenza virus in eggs before the virus is processed into the vaccine to activate the proper immune response.
Currently, the World Health Organization (WHO) convenes a group of influenza experts each year to study the flu that circulates among populations in the southern hemisphere of the globe to determine which strains of the virus should be targeted in a vaccine for the northern hemisphere, where colder climates generally contribute to worse flu seasons. Such analysis is reliable but not always accurate, and can lead to mismatches that produce weak vaccines. “We see this play out in [vaccine] efficacy that ranges anywhere from 50% to 60% in a good year to 20% in a not-so-good year,” says Marrazzo. But with an mRNA-based flu shot, manufacturers won't need as much lead time to develop the vaccine, and could therefore better track and match influenza strains causing disease in real time.
Moderna plans to have mFlusiva available in the fall as flu vaccine campaigns start, but only for a select group of people. The FDA approved the shot for people ages 50 and older, the group that recently-revised U.S. government guidelines say should be receiving flu shots every year. The current recommendations differ from previous guidelines, which advised that anyone six years and older, including pregnant women, should be vaccinated against both flu and COVID every year. While the CDC continues to make this recommendation on its website, in January, the Trump Administration revised this guidance for routine vaccination and instead shifted the decision to vaccinate to individual families and their physicians. Disagreeing with the change, many health organizations—including the American Academy of Pediatrics, the American Medical Association, and the American College of Obstetricians and Gynecologists—continue to recommend yearly flu shots for most people.
The approval of the first mRNA flu vaccine is an important milestone for public health, says Marrazzo, but it's tempered by the current U.S. political environment that fuels skepticism about both the effectiveness and safety of vaccines in general, and about mRNA technology in particular. “We have never been technically at a more exciting time in terms of mRNA vaccines. There are all kinds of incredibly cool stuff happening," she says. "Yet in the public eye, we are taking five steps backward as trustworthy emissaries for the advancement of science, all due to the undermining of research and our credibility as trusted advisors.”
mFlusiva's road to approval exemplifies this now-fraught environment for vaccines in the U.S., after the FDA initially dropped it from review in February. The agency sent Moderna a “Refusal-to-File” letter, notifying the company that it would not review the vaccine and stating that the study did not provide a proper control arm against which to compare mFlusiva, and that using existing flu shots as comparators “does not reflect the best-available standard of care.” In prior discussions before submitting its request for approval, the FDA suggested that the company provide data comparing mFlusiva among those 65 years or older to higher dose flu vaccines for this older population, which is at higher risk of complications from flu. Moderna says it provided the additional data.
After receiving the Refusal-to-File letter, Moderna’s executives and scientists met with the FDA and agreed to seek full approval for people 50 to 64 years old, and accelerated approval for people 65 years or older, as well as conduct another study in the latter population. Under FDA’s accelerated approval, drugs can be approved sooner based on results of early benefit while further studies on longer term benefit are completed. Days after refusing to review the mRNA flu shot, the FDA decided to consider it for approval.
Marrazzo says she can’t think of another drug that experienced such about-face decisions from the FDA. “It’s hard to read as anything other than a political decision from above,” she says. “I don’t know for certain if that’s true, but that’s my supposition, if you trace back to Secretary [Robert F.] Kennedy’s overt hostility to mRNA vaccines. It’s a really good thing that there was a reconsideration and that science won out.” Kennedy, who heads the Department of Health and Human Services that oversees the FDA, is a longtime skeptic of vaccines. In 2025, he halted 22 projects, worth $500 million, focused on developing mRNA vaccines for respiratory diseases, including for pandemic flu.
Mixed signals from federal health authorities are contributing to confusion among the public, who are increasingly questioning the effectiveness and safety of vaccines, despite what scientists maintain is a strong track record of their benefit with relatively low risk. One of the reasons people are reluctant to get a flu shot is because of its sometimes weak effectiveness in protecting against symptoms. But an mRNA-based vaccine should improve on that since its shorter development time gives manufacturers a better chance of matching influenza strains in real time. “Will the public buy it? That’s another question entirely,” says Marrazzo.
50 оттенков NGFW, часть вторая
Привет, Хабр! Как и обещали — вторая часть истории про то, как мы строим InfoWatch ARMA Стена (NGFW) в текущих реалиях. Первая часть — тут.
Сегодня про:
- ИИ и нейросети
- миграцию
- отечественное железо
- почему NGFW, а не data diode
- цены и пилотирование
ИИ сейчас почти из каждого утюга. Как у вас с этим дела в продукте?
С точки зрения технологий мы не отдаем обработку данных в облако или стороннему агенту — большинство заказчиков против подобного, а их политики безопасности вообще часто прямо запрещают подобную обработку, особенно при прохождении ПМИ и испытаний. Внутри системы мы агентов тоже не разворачиваем.
Да, для отдельных команд есть специальные службы и агенты, помогающие настроить предварительные сценарии эксплуатации и ускорить некоторые процессы — в основном исследовательские: поиск уязвимостей, описание уникальных конфигураций, способных вывести систему в аварийный режим, и подобное. Важно всегда помнить, что нейронка — это лишь инструмент помощи специалисту. Конечное решение всегда принимает человек — инженер, который и отвечает за конкретную ветку продукта.
Мы используем и собственные модели для обучения системы новым фидам. Когда появляются новые эксплойты, время реакции нашей команды безопасности заметно быстрее, чем у большинства игроков рынка. Наш приоритет тут — надежность и стабильность, а значит, в первую очередь безопасность. NGFW для нас — сначала инструмент безопасности, и только потом — инструмент сетевой связанности.
Читать далееПочему я перестал верить, что хороший продукт можно придумать заранее
Первые проблемы мы заметили, когда добавили скелетоны загрузки. С виду всё было красиво: плавная анимация, приятные цвета в тон интерфейсу. Мы думали, что человек увидить экран загрузки и спокойно подождет. Но пользователь действовал иначе: дёргал мышкой, переключал вкладку и перезагружал страницу.
Читать далееUkraine hits two oil refineries deep in Russian territory
U.S. hit with more foodborne illnesses as Chipotle, Qdoba remove salmonella-linked jalapeños
Hampshire and England bowler Turner retires aged 25
Trump administration moves to deregulate Head Start, opening door for sweeping change
It would slim regulation of the 60-year-old anti-poverty program and aim to save money. Advocates worry the changes could undermine the early education program's mission.
(Image credit: AP Photo/Lindsey Wasson)
Miss North Carolina USA stripped of title after alleged racist posts resurface
First runner-up, Myla Hadley, will represent the state at the Miss USA pageant after Brittany Boltinhouse’s removal
A pageant queen recently crowned Miss North Carolina USA has been stripped of her title after a string of alleged racist posts resurfaced.
Brittany Boltinhouse, 27, was formally dethroned on Wednesday by pageant organizers A Blaize Productions after what it said was “a thorough review of recently surfaced information”.
Continue reading...Jason Arday claimed he was paid ‘1.4 million’ for memoir from publisher
Academic who resigned as a Cambridge professor on Wednesday did not specify if amount from Simon & Schuster was in pounds or US dollars
Jason Arday, the former Cambridge professor accused of plagiarism and embellishment, claimed he was paid “1.4 million” for his forthcoming memoir detailing his extraordinary backstory.
Arday was dogged by a growing series of questions over his academic work and credentials before he resigned on Wednesday night, saying the “relentless accusations, speculation and public commentary have taken a profound toll on me and on those I love”.
Continue reading...Nearly 50 asylum seekers deported under ‘one in one out’ scheme have returned to the UK
Figure raises questions about deal with France despite UK ministers insisting repeat arrivals will be removed
Almost 50 asylum seekers deported using the “one in one out” scheme have been recorded as returning to the UK a second time, the Guardian has learned.
In addition to the returnees detained by the Home Office, an unknown number are believed to have arrived in the UK undetected.
Continue reading...[Перевод] Как VictoriaLogs хранит логи в колоночной структуре
Если вы эксплуатируете VictoriaLogs, повседневная работа сводится к трём вещам: отправке логов, выполнению запросов и настройке срока хранения, чтобы не переполнить диск. Всё остальное незаметно происходит на диске.
В этой статье мы проследим путь одной записи лога — от поступления в VictoriaLogs до окончательного размещения на диске. Это поможет представить, что происходит внутри системы, и понять наблюдаемое поведение: почему запросы выполняются быстро, почему на диске иногда появляется множество файлов и какие флаги и метрики важны при поиске неполадок. Статья рассчитана на широкую аудиторию: не требуется ни опыт программирования, ни знание Go. Тем, кто захочет разобраться глубже, первоисточником послужит исходный код VictoriaLogs.
Читать далееPrintln Debugging Done Right
The simplest tools are often the most useful, and debugging is a prime example of this.
There are many advanced debugging techniques, and while they all have their use cases, println debugging is still the #1 choice, whether you’re doing it manually or with the help of coding agents.
Inserting a println statement to inspect a program’s state is one of the first things novice developers do, even before they hear the word “debugging”. Years later, simple debug logging remains one of the most useful tools for diagnosing all sorts of problems in real codebases. And now, it’s also one of the favorite tools of coding agents.
Better foundation + modern workflows
The technique can be improved without losing its original simplicity. In fact, IntelliJ IDEA’s logpoints have long been a more capable superset of println debugging: While performing the same function, they can also be conditional, print stack traces, use hit counters and caller filters, be grouped, saved for later, and much more. If you try to imagine the most unusual debugging use case, chances are IntelliJ IDEA’s logpoints already have a feature for it (for example, did you know they can beep?).
In 2026.2, we’re taking logpoints further with several improvements focused less on specific use cases and more on strengthening the foundation:
- Instrumentation instead of debugger-side evaluation: IntelliJ IDEA now instruments your code directly for conditional and logging breakpoints, removing the bottleneck that other Java debuggers have.
- Agent compatibility: We’ve revised logpoints so they can be used reliably by AI agents. Together with a new bundled skill, this gives agents the guidelines and handles they need to control the debugging session and use all the logpoint features of the IDE.
- New UI and navigation: The new UI makes logpoints easier to set up. In addition, the console now tracks which println or logpoint produced each logging entry, letting you navigate there.
All these features are supported in both local and remote JVM debug sessions.
Let’s look more closely at each of them.
A short demo
For this demo, I set up a mini gRPC server/client scenario, in which we’re supposed to debug the server side. For those new to logpoints, the next post in this series will feature a detailed tutorial based on this project. For now, let’s examine the new features.
In this particular case, suspending the app with a regular breakpoint is useless. If we try to do so, the timeout expires quickly, and execution follows the cancellation path, hiding the state we were going to inspect.
So, instead of using a breakpoint, let’s log the state, preferably with a coding agent doing it for us:
The agent not only sets the logpoints but also executes the run configurations, summarizes the resulting logs, finds the bug, and cleans up after itself.
Since IntelliJ IDEA tracks which logpoints belong to the agent, the agent cannot accidentally change yours. It does have full control over its own logpoints, though, including toggling them and modifying any properties that you can. When changing state is necessary for reproducing the bug, IntelliJ IDEA lets agents do that, but the skill steers the agent to avoid side effects and prefer logpoints whenever possible.
Here’s a short video showing how that works:
Run from the terminal
In the example above, we’re running the agent through the AI chat, but the same works equally well with agents in the built-in terminal or outside the IDE. Once the skill is installed, it becomes available in the agent of your choice:
The workflow is the same, this time with Claude Code:
Setting logpoints manually
Setting logpoints manually now takes a single click: Select the expression to log, and then click in the gutter between any two executable lines. If the expression is not in front of you in the editor, you can enter a custom expression afterwards:
To find out which piece of code produced a specific line in the console, click the line and then select Open:
IntelliJ IDEA will show the Open button that brings you to the corresponding code in the editor. Additionally, if it comes from an instrumented logpoint, the IDE will show the stack trace of how it got there – you get the same information as with the Log stack trace option, but now without cluttering the console with noisy messages.
How much faster have logpoints become?
Many benefits of logpoints are shared across debuggers:
- Logpoints do not require source changes.
- They are easy to turn on and off.
- They let you inspect code that would otherwise be inconvenient to modify.
IntelliJ IDEA’s implementation has many advantages beyond the basics, but performance is what stands out in this release.
If you’ve ever put a conditional or logging breakpoint in a hot path, you’ve seen the cost. With the traditional JPDA/JDWP breakpoint model, every hit suspends the application, evaluates the condition/log expression, and then resumes execution. For occasional hits this is fine, but in hot paths, this standard model becomes a bottleneck.
The overhead of traditional Java logpoints is not just a nuisance. The delay could hide a latency-sensitive failure, make a race condition disappear, or throttle the application load in a way that masks the problem. There’s a real risk that you would be debugging behavior introduced by the debugger itself.
Some time ago, I wrote about ways to work around this. Luckily, IntelliJ IDEA 2026.2 makes these hacks obsolete by instrumenting the debugged code for conditional and logging breakpoints. This chart shows the results of our internal benchmarking:
In our test set, the improvement is around 30x, making logpoints usable again in timing-sensitive code. You keep the same logpoint workflow, and so do agents, now with the performance of a regular print statement.
The best part is, you don’t need to do any setup to enjoy this speedup. IntelliJ IDEA will automatically detect logpoints that can be instrumented and do so behind the scenes in the same debug session, with no restart required.
Summary
Logpoints are still the same simple idea that makes println debugging great: Obtain the right bit of information and put it in the most accessible place. And with the new pieces, this technique becomes even more useful for both developers and AI agents.
More agent skills and debugger capabilities are on the way. If there is a debugging workflow you would like agents to handle, tell us in the comments under this post. And if you have a concrete feature request for IntelliJ IDEA, please file it in our YouTrack so it doesn’t go unnoticed.
Happy debugging!
Record number of referrals to counter-terror programme as cases surge
Amid legal battles, Suno says it will start watermarking songs
Female police officer 'seriously bitten' during anti-migrant violence
US Senate panel votes to hold Fauci in contempt of Congress over Covid hearing
Anthony Fauci’s lawyer condemned the vote from the Republican-controlled committee as a ‘crude political stunt’
A Republican-controlled US Senate committee voted to hold Dr Anthony Fauci in contempt of Congress after the veteran public health official repeatedly pleaded the fifth amendment to parry a hostile inquisition into his stewardship of the response to the Covid-19 pandemic.
Fauci, the former director of National Institute of Allergy and Infectious Diseases (Niaid), who led the agency for 38 years before retiring in 2022, gave the same response to dozens of questions while refusing to give clarifying answers during a tense hearing last week, citing his constitutional protections.
Continue reading...Barcelona step up Rodri interest after Real Madrid talks with Manchester City star stall
Barça ready to hijack rivals’ plans to sign Spain captain
Manchester City will allow midfielder to go for £60m
Barcelona have stepped up their attempts to hijack Real Madrid’s move to sign Rodri from Manchester City.
While City have not given up hope that Spain’s World Cup-winning captain will sign a new contract after he entered the final year of his deal, they are thought to be willing to allow him to leave for about £60m. Despite weeks of talks with Rodri and his representatives, Real have yet to reach an agreement and Barcelona are hoping to take advantage.
Continue reading...US Senate panel votes to hold Fauci in contempt of Congress over Covid hearing
Anthony Fauci’s lawyer condemned the vote from the Republican-controlled committee as a ‘crude political stunt’
A Republican-controlled US Senate committee voted to hold Dr Anthony Fauci in contempt of Congress after the veteran public health official repeatedly pleaded the fifth amendment to parry a hostile inquisition into his stewardship of the response to the Covid-19 pandemic.
Fauci, the former director of National Institute of Allergy and Infectious Diseases (Niaid), who led the agency for 38 years before retiring in 2022, gave the same response to dozens of questions while refusing to give clarifying answers during a tense hearing last week, citing his constitutional protections.
Continue reading...Bombs, heists and big cats: TV’s 25 best true-crime shows ever
From mind-boggling murder investigations to decade-long scams, there’s no shortage of documentaries about real-life awfulness. We list the most incredible
Since the true-crime explosion a decade ago – kickstarted by Netflix’s Making a Murderer – audiences have been fed a steady small-screen diet of cold-case killings, catfishing scams and creepy cults. And, after years of varying results, Netflix’s latest show, A Toxic Love Story – which recounts how a California couple framed an innocent woman for stalking, intimidation and recruiting men from Craigslist to rape her ex’s new wife – is being billed as a return to true-crime form. But when it comes to similar shows worth your viewing time, what else is up there?
Here’s a selection of the genre’s 25 standout shows and where to watch them – which, let’s face it, is mainly Netflix. Let the boggle-eyed bingeing begin.
Continue reading...«Российский суд признал — авторское право не защищает картинки из нейросетей!»: так ли это и что произошло на самом деле
Ох уж эти журналисты! На прошлой неделе по СМИ полетела «шок-новость» о «новом» решении российского суда.
Суть дела: человек сделал две картинки нейросетью, предприниматель взял эти две картинки и выставил футболки с ними в своем интернет-магазине. Человек подал в суд на предпринимателя, потребовал компенсацию, суд отказал.
Что дальше началось в СМИ, это жесть:
— «Авторские права на картинки из нейросетей больше не действуют!»
— «Нейроарт теперь не творчество, официально!»
— «Теперь всем «нейронщикам» будут отказывать!»
Я как юрист по авторским правам нашел это дело, вычитал решение и готов рассказать, что там произошло на самом деле.
Эта занимательная история пригодится всем, кто использует нейросети сам, с коллегами или нанимает подрядчиков.
Интересные факты, о которых не написали в СМИ:
Читать далее10 лет разработки, 300 млн ₽ вложений и 460 тысяч пользователей: история платформы корпоративных скидок
Иногда продукт развивается годами. Без громких новостей, без венчурных фондов и без взрывного роста. Команда постепенно дорабатывает систему, переживает кризисы, меняет подходы, исправляет ошибки и шаг за шагом строит бизнес.
История Николая именно такая.
Читать далееEye Opener: U.S. hit with more foodborne illnesses
Where the Trump administration's lawsuits seeking voter data stand
Ohio voters reconsider Republican Max Miller amid domestic abuse allegations
Voters in the red district are concerned with congressman’s alleged behavior and political future ahead of the midterms
David Griffith was a registered Republican for years.
But on Sunday evening, he watched Ohio congressman Max Miller stumble through an 18-minute statement in which the lawmaker attempted to defend himself against allegations of domestic abuse against his ex-wife and infant child.
Continue reading...Blogger Perez Hilton receiving medical care after appearing to self-harm online
This country is the latest to hit the elusive 95/95/95 HIV target
The United Nations has set a goal for near universal HIV diagnosis and treatment for all by 2030. No country in Asia has hit the mark — until this year.
(Image credit: Tang Chhin Sothy)
Senate committee votes to hold Fauci in contempt of Congress
Группировка ошибок и анализ причин падений (RCA) с помощью ИИ
Последние годы стали серьёзным испытанием для тестирования.
Нейросети существенно ускорили разработку кода: интеграция ИИ-помощников в IDE позволила за минуты решать задачи, на которые раньше нужны были часы. Качество иногда страдает, но высвобожденное время в сумме даёт положительный эффект, и в итоге количество поставляемого кода резко растёт.
В то же время пропускная способность QA принципиально не изменилась. Тестировщики тоже пользуются нейросетевыми помощниками, но им для успешной работы обычно нужно больше контекста — а значит, больше инфраструктуры.
В этой статье я хочу привлечь внимание к тому, насколько большую роль подготовка данных играет для нейросетей в QA. Конкретно, речь пойдёт о группировке падений перед анализом их причин. Я буду анализировать запуски инструментом для автоматической отладки багов — playwright-ai/auto-debug.
Читать далее114 days and counting - how damaging is Alcaraz's wrist injury?
Как внедрять MLSecOps: пять этапов практического road-map
MLSecOps переносит принципы DevSecOps на ИИ-системы. Он делает безопасность измеримой, воспроизводимой и встроенной в разработку и эксплуатацию, а не «прикрученной» в конце. В этой статье мы описываем практический road-map из пяти этапов, который позволяет последовательно выстроить этот контур: от видимости и политик к управляемому доступу, контролю кода, runtime-защите и полноценным AI Security Operations.
Этапы нельзя перепрыгивать. Каждый последующий опирается на результаты предыдущего. Расскажем про конкретные шаги, типы инструментов и метрики, по которым можно понять, что система действительно работает.
Читать далееSenate committee votes to hold Fauci in contempt of Congress
Ракета SpaceX, вероятно, уже столкнулась с Луной
Politics
No content available